CureVac to 'plow forward' with Covid vaccine despite disappointing results

CureVac plans to continue work on its Covid-19 vaccine despite disappointing clinical trial results that showed the shot is just 48% effective.

Read alsoHong Kong's zero-Covid approach is the main issue frustrating businesses there, says analyst

Read alsoEuropean markets look for rebound as investors assess omicron risk; Stoxx 600 up 1%

Read alsoThe country that celebrates Christmas for more than 4 months a year

Read alsoAmazon drivers sought safety at warehouse as tornado hit but found only death and destruction

http://dlvr.it/S2tGjd